通过IGF2BP3识别的N6-甲基亚诺辛修饰的SRD5A3,在膀癌中维持了对西斯的耐药性
Kai Liao1, Jing Li2, Caixian He3
1Department of Radiotherapy, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, No. 78 Hengzhigang, Yuexiu District, Guangzhou, 510095, China. coolio620@163.com.
Human cell
|December 16, 2024
概括
这项研究揭示了N6-甲基氨酸 (m6A) 修饰,特别是涉及IGF2BP3和SRD5A3,如何在膀癌中驱动西斯普拉丁耐药性. 针对这种途径为膀癌患者提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 西斯普拉丁耐药性限制了膀癌治疗的有效性.
- N6-甲基氨酸 (m6A) 修饰是一种癌症中新兴的表观遗传机制.
- 了解m6A在西斯普拉丁耐药性中的作用对于治疗优化至关重要.
研究的目的:
- 为了研究m6A修饰在膀癌中对西斯普拉丁耐药性的作用.
- 为了确定参与这种表观遗传调节的关键分子.
- 探索潜在的治疗点,以克服西斯的耐药性.
主要方法:
- 在膀癌组织和细胞系中分析SRD5A3和IGF2BP3表达.
- 细胞增殖和化学抵抗测定 (CCK-8,殖民地形成,EDU,流细胞计).
- 分子技术包括m6A免疫沉降,RNA免疫沉降和光酶记者测试.
- 在体内研究使用裸体老鼠异种移植模型.
主要成果:
- 在膀癌中,SRD5A3的表达升高,特别是在抗西斯的细胞中.
- 通过m6A修饰,IGF2BP3稳定SRD5A3mRNA,从而促进对西斯的耐药性.
- 抑制SRD5A3或IGF2BP3可以减少细胞增殖和逆转化疗抵抗.
- 在体内,SRD5A3和IGF2BP3敲击抑制了对西斯普拉丁耐药模型的瘤生长.
结论:
- 通过IGF2BP3介导的SRD5A3的m6A修饰促进了膀癌的进展和对西斯普拉丁的抗性.
- 在膀癌中,SRD5A3和IGF2BP3代表了克服西斯普拉丁耐药性的潜在治疗点.
- 这项研究提供了关于化学抵抗背后的表观遗传机制的见解.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


